Although there are some similarities and dissimilarities between DNA and RNA polymerase as enzymes, when polymerase encounters a DNA lesion, the polymerase proceeds with one of two actions. One is to stall at the DNA lesion, which results in DNA repair mechanisms or cell death being induced. The other is for the polymerase to bypass the DNA lesion, which results in a mutation that could subsequently lead to carcinogenesis. The eŠects of DNA lesions, on either DNA polymerases or RNA polymerases, might be dependent on the cell cycle. This is because DNA polymerase in replication and RNA polymerase in transcription operate in the S phase and the G0 phase of the cell cycle in human cells, respectively. In addition, lesions may vary in their eŠects among the many cell types in the human body. Most diŠerentiated cells, like cardiomyocytes and neurons, are post-mitotic, non-dividing cells. Some somatic cells, stem cells, and cancer cells are dividing cells in which DNA replication occurs in the S phase. To re-evaluate the biological risk conveyed by DNA lesions in living human cells, studies on cell-cycle-dependent actions of both DNA polymerase and RNA polymerase on DNA templates that contain lesions might be required.
Introduction
DNA is vulnerable to damage by many endogenous and exogenous agents. The DNA lesions that can result from such damage interfere with DNA replication and can induce mutations via replication by DNA polymerases or translesion DNA polymerases (1-3). Therefore, it is important to study the action of DNA polymerases at DNA lesions. However, DNA lesions interfere not only with replication, but also with transcription. Here, it is proposed that, in order to provide an accurate estimate of the risk conveyed by DNA damage to living cells, an understanding of the eŠects that DNA lesions induced by environmental mutagens and carcinogens have on transcription is also important (4, 5) .
The eŠects of DNA lesions, on either DNA polymerases or RNA polymerases, will be dependent on the cell cycle. The cell cycle basically consists of four distinct phases: G1, S, G2, and M. The S phase is when DNA replication occurs and replicative DNA polymerases synthesize new DNA strands using complementary DNA templates. In the S phase, most DNA polymerases, DNA polymerase alpha, delta, and epsilon, will encounter DNA lesions, but not so many RNA polymerases are active, for example, RNA polymerase II that transcribes messenger RNAs. The G0 phase is a quiescent period that occurs outside of the cell cycle instead of the G1 phase, during which replication does not occur, but transcription does. Therefore, in this phase, RNA polymerases will frequently encounter DNA lesions (6, 7) .
DNA lesions may vary in their eŠects among the many cell types in human body. Normal or cancer cell lines in laboratories are generally maintained in an environment favorable to growth, in which conditions are optimized for the cell cycle, DNA repair, prevention of apoptosis, and many aspects of cellular metabolism. However, the majority of cells within the human body are not exposed to such experimental conditions. Many cells are terminally diŠerentiated, post-mitotic cells that carry out transcription and translation at extremely high levels, but not replication. In contrast, some stem cells are dividing cells in which DNA replication occurs in the S phase for the diŠerentiation. And cancer cells are rapidly dividing cells and constantly undergo cell division (1, 8, 9) . Although lesions on a DNA template can block DNA polymerase and induce mutations in DNA during replication in cells that pass through S phase, lesions on a transcribed strand can block RNA polymerase and lead to``mutations'' in RNA transcripts during transcription in terminally diŠerentiated cells. Therefore, for estimating the genotoxicity of DNA lesions in human organs, transcription events, as well as replication events, are thought to be important for toxicological studies.
This article will focus on the actions of DNA and RNA polymerases on damaged DNA templates, the induction of mutations by translesion synthesis at speciˆc sites containing DNA lesions, and how these mutations 
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The EŠects of DNA Lesions are dependent on the cell cycle. In addition, the biological risk conveyed by DNA lesions in living human cells will also be discussed.
When DNA Polymerases Encounter DNA Lesions
All living organisms, from bacteria to mammals, consist of cells that divide and multiply. The cell cycle is the essential process by which these divisions occur. When cells are exposed to agents that damage DNA in the S phase of the cell cycle, DNA polymerases frequently encounter DNA lesions. Stalling or pausing as a result of a failure to synthesize DNA beyond a lesion leads to the activation of DNA repair systems (homologous recombination repair (HRR), nucleotide excision repair (NER) and base excision repair (BER)). Since replication blocking by DNA lesions often causes doublestranded DNA breaks, HRR is the type of DNA repair that is most often activated in such cases (Fig. 1A) . This is because HRR is capable of providing an identical homologous sequence as a template for repair. When cells employ HRR, no errors in the DNA sequence should remain (1, 10, 11) .
On the other hand, when replicative DNA polymerases, but not translesion DNA polymerases, bypass DNA lesions, mutations are produced in the newly synthesized DNA strands. For example, a UV-induced DNA lesion, cyclobutane pyrimidine dimer (CPD), blocks replicative DNA polymerases. However, the translesion DNA polymerase eta, which is encoded by a gene of which mutations cause the disease xeroderma pigmentosum variants (12, 13) , enables bypassing of CPD without any mutations being formed thanks to insertion of the correct bases opposite the lesion (14) . In contrast, as an example of a lesion that the oxidative DNA lesion, 7,8-dihydro-8-oxoguanine (8-oxoG) is one of the major DNA lesions induced by oxidative stress. The lesion is non-bulky, non-distorting, and has the capability to form a Hoogsteen pair with adenine or a normal Watson-Crick pair with cytosine (15, 16) . Therefore, DNA polymerases can easily bypass this lesion. These characteristics mean that 8-oxoG, through DNA replication in the S phase, results in a G:C to T:A transversion (Fig. 1B) .
When RNA Polymerases Encounter DNA Lesions
Mammalian cells in laboratories are generally maintained in a favorable growth environment to promote viable replication by facilitating cell cycle progression and many aspects of cellular metabolism. However, the majority of cells in humans are not exposed to such conditions. There are many terminally diŠerentiated cells, like heart muscle cells and nerve cells (neurons), which are in G0 phase and exhibit extremely high levels of transcription and translation, but not replication. In these cases, RNA polymerases, rather than DNA polymerases, will frequently encounter DNA lesions. Transcriptional machinery stalls at sites of damage on DNA strands that are being transcribed, and this stalling is thought to trigger the activation of transcription-coupled repair (TC-NER or TC-BER) systems (1, 4) . CPD and another UV-induced DNA lesion, pyrimidine(6-4) pyrimidine photoproduct (6-4 pp), are repaired by TC-NER; the levels of e‹ciency of TC-NER for repairing these two types of lesion are the same. This is because both of these DNA lesions on a transcribed strand block RNA polymerase equally (17, 18) . As another example, the oxidative DNA lesion thymine glycol (Tg) repaired by BER can block RNA polymerase; therefore, there is a possibility that the DNA lesions are subjected to TC-BER (Fig. 1C) . In such cases, excision repair (NER and BER) can participate in removing the DNA lesions because there is a template for DNA repair synthesis in genomic DNA in the G0 phase (19) (20) (21) .
RNA polymerases, like DNA polymerases, can also induce``mutations'' in transcripts (transcriptional mutagenesis: TM). In fact, like 8-oxoG and uracil (product of cytosine deamination) during replication induce G:C to T:A transversions and C:G to T:A transitions, both lesions in the transcribed strand during transcription induce``C to A transversions in transcript'' and``G to A transitions in transcript'', respectively (22, 23) . This suggests that the adenine misincorporation at these DNA lesions during replication and transcrip- 
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Isao Kuraoka tion occurs by using the stable base pairing, which is generated by these structurally unrelated DNA and RNA polymerases. Base pair formation within DNA lesions might be important for DNA or RNA mutagenesis (24) . To date, some translesion DNA polymerases have been identiˆed in human cells, but translesion RNA polymerases have not. RNA polymerase II can bypass 8-oxoG and Tg e‹ciently in the presence of transcription factors SII and TFIIF, respectively, although these additional factors cannot help to reduce the``mutation'' rate in transcripts (19, 20) . When RNA polymerases bypass DNA lesions that can induce mispairing, RNA polymerase would generate mutant transcripts (Fig.  1D) .
Where DNA Polymerases Encounter DNA Lesions
The issue of when polymerases encounter DNA lesions is closely linked to the issue of where they encounter such lesions. This is because both issues depend on the cell cycle. There are many diŠerent cell types in human body, which means that cell cycle duration varies according to cell type. Most terminally diŠerentiated cells have limited potential to divide by mitosis, with few passing through the S phase of the cell cycle. This contrasts with stem cells that have diŠerentiation potential and can divide by mitosis into two stem cells. In addition, myeloid cells, epidermal cells, intestinal epithelial cells, and cancer cells are dividing cells that often progress to the S phase. Given this background, DNA polymerases will frequently encounter DNA lesions. Bypassing of DNA lesions by DNA polymerases in the replication machinery would induce mutations in DNA and theˆxed mutations would also lead to mutant transcript production through the transcription machinery. If a premature translation-termination codon is generated by a``mutation'' in a transcript, nonsense-mediated mRNA decay (NMD) can remove the transcript (25, 26) . However, other types of``mutant'' transcripts could be produced. Eventually, these``mutation'' transcripts would lead to``mutant'' proteins. In cellular proliferation,``mutations'' in cell growth factor-related proteins, such as epidermal growth factor receptor (EGFR) and KRAS (27, 28) , may have markedly negative eŠects. In addition, there is a possibility that strand exchange during HRR activated to repair a DNA lesion in the S phase would lead to truncated proteins and mutant proteins ( Fig. 2A) .
Where RNA Polymerases Encounter DNA Lesions Non-dividing, terminally diŠerentiated cells, such as myotubes, adipocytes, and neurons, represent a special case compared with other cells in which replication occurs. Since these cells do not replicate their DNA, the risk of them accumulating carcinogenic mutations is extremely low. However, they do transcribe their DNA. When RNA polymerases stall at a DNA lesion, such as at the oxidative DNA lesion 5',8-cyclo-2-deoxyadenosine, TCR would remove the lesion (29) . However, when RNA polymerases bypass a DNA lesion, such as a non-bulky DNA lesion 8-oxoG or uracil,``mutant'' transcripts not removed by NMD would be produced and their transcripts would generate``mutant'' proteins in the non-dividing cells. Such non-functional or dysfunctional``mutant'' proteins would be harmful. If no repair mechanism could be generated, DNA damage-induced apoptosis would result, with consequent uncompensated cell loss for the organism. In this harmful situation in the case of terminally diŠerentiated neurons, neurogenic problems rather than carcinogenic ones might be the resulting disease phenotype. An example of this harm is when healthy cellular metabolism is dramatically aŠected by the stalling of RNA polymerase due to not only DNA lesions but also the RNA polymerase II inhibitor, alpha-amanitin (4, 30) . In any case, the eŠects of RNA polymerase bypassing DNA lesions in nondividing cells would be a major source of``mutant'' proteins (Fig. 2B) .
Conclusion
Estimating the eŠects of DNA lesions on replication by DNA polymerase is very important for research on mutagenesis and carcinogenesis due to chemical agents. It is here proposed that estimation of the eŠects of DNA lesions on transcription might be essential for explaining neurological and cellular metabolism dysfunction in human cells, which impacts on the quality of life.
